| Item | Cat. No. | Application | Isotype |
| Anti-CBX8 mAbs [RAB-C291](MABL-641) | MABL-641 | IP-MS, IF | Engineer antibody |
| Anti-CCL18 mAbs [AZN-CK18](MABL-642) | MABL-642 | IP, ELISA, FC, IHC | Engineer antibody |
| Anti-CCL2 mAbs [AAV293](MABL-643) | MABL-643 | inhibition, ELISA | Engineer antibody |
| Anti-CCL2 mAbs [CNTO 888 (Carlumab)](MABL-644) | MABL-644 | inhibit, therapeutic, Block | Engineer antibody |
| Anti-CCL2 mAbs [MC32 affinity matured](MABL-645) | MABL-645 | Block, ELISA | Engineer antibody |
| Anti-CCL2/CCL12 mAbs [11k2](MABL-646) | MABL-646 | Block, ELISA | Engineer antibody |
| Anti-CCL20 mAbs [AB1](MABL-647) | MABL-647 | in vitro, SPR, ELISA | Engineer antibody |
| Anti-CCP mAbs [AbAb01-CCP](MABL-648) | MABL-648 | ELISA | Engineer antibody |
| Anti-CCR2 mAbs [4.9](MABL-649) | MABL-649 | antagonist, ELISA, FC | Engineer antibody |
| Anti-CCR2 mAbs [AbAb-CCR2](MABL-650) | MABL-650 | Block, FC | Engineer antibody |
| Anti-CCR3 (CD193) mAbs [5E8-G9-B4](MABL-651) | MABL-651 | FC | Engineer antibody |
| Anti-CCR5 (phosphoserine 337) mAbs [V14/2](MABL-652) | MABL-652 | IP, WB, ELISA, FC, IF | Engineer antibody |
| Anti-CCR5 (phosphoserine 349) mAbs [E11/19](MABL-653) | MABL-653 | IP, WB, ELISA, IF | Engineer antibody |
| Anti-CCR5 (PKC site) mAbs [RC-10](MABL-654) | MABL-654 | WB, ELISA, IF | Engineer antibody |
| Anti-CCR5 mAbs [T21/8](MABL-655) | MABL-655 | IP, WB, ELISA, FC, IF | Engineer antibody |
| Anti-CCR7 mAbs [4B12](MABL-656) | MABL-656 | functional assays, IP, FC | Engineer antibody |
| Anti-CCR7 mAbs [6B4.1](MABL-657) | MABL-657 | inhibition, ELISA | Engineer antibody |
| Anti-CCR7 mAbs [6E1.2](MABL-658) | MABL-658 | inhibition, ELISA | Engineer antibody |
| Anti-CCR7 mAbs [mAb 22](MABL-659) | MABL-659 | Blocking, ELISA | Engineer antibody |
| Anti-CCR9 mAbs [9B1](MABL-660) | MABL-660 | neutralizing, FC | Engineer antibody |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
